ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

Completed · Phase 2

Conditions studied: Ovarian Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of ISIS 5132 in treating patients who have metastatic or recurrent ovarian cancer that has not responded to previous chemotherapy.

Key facts

Study ID
NCT00003892
Run by
NCIC Clinical Trials Group
People needed
22
Starts
1999-02-01
Expected to finish
2008-09-22
Last updated by the study team
2020-04-06

Who can join

Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.